Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering of Saccharomyces cerevisiae as a consolidated bioprocessing host to produce cellulosic ethanol: Recent advancements and current challenges.

Biotechnology advances·2022
Same author

New Horizons: Molecular Basis and Novel Therapeutics in Congenital Adrenal Hyperplasia.

Indian journal of clinical biochemistry : IJCB·2022
Same author

Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata.

mBio·2022
Same author

Graphene Oxide Supported Liposomes as Red Emissive Theranostics for Phototriggered Tissue Visualization and Tumor Regression.

ACS applied bio materials·2022
Same author

Characteristics of Molecularly Engineered Anticancer Drug Conjugated Organic Nanomicelles for Site-Selective Cancer Cell Rupture and Growth Inhibition of Tumor Spheroids.

ACS applied bio materials·2022
Same author

Ultrahigh Penetration and Retention of Graphene Quantum Dot Mesoporous Silica Nanohybrids for Image Guided Tumor Regression.

ACS applied bio materials·2022
Same journal

Gynandroblastoma: a rare ovarian tumour with an unusual clinical presentation.

Journal of the Indian Medical Association·2015
Same journal

Bilateral hip and knee arthroplasty in ochronotic arthritis.

Journal of the Indian Medical Association·2015
Same journal

Biliary colic with dilated common bile duct: simple "sheepish" problem?

Journal of the Indian Medical Association·2015
Same journal

Proximal femoral focal deficiency revisited: a case report.

Journal of the Indian Medical Association·2015
Same journal

Disseminated intra-abdominal hydatid disease: surgical management.

Journal of the Indian Medical Association·2015
Same journal

Eosinophilic ascitis, an unusual presentation of eosinophilic gastro-enteritis.

Journal of the Indian Medical Association·2015
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Revised National Tuberculosis Control Programme: current scenario.

Rajendra Prasad1

  • 1Department of Pulmonary Medicine, CSM Medical University, Lucknow 226003.

Journal of the Indian Medical Association
|May 18, 2010
PubMed
Summary
This summary is machine-generated.

Tuberculosis is curable, but remains a leading cause of death in developing nations. India

Related Experiment Videos

Last Updated: Jun 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Tuberculosis (TB) remains a significant global health challenge, particularly in developing countries.
  • The Revised National Tuberculosis Control Programme (RNTCP) in India utilizes Directly Observed Treatment, Short-course (DOTS) strategy.
  • Despite progress, multidrug-resistant tuberculosis (MDR-TB) poses a growing threat.

Purpose of the Study:

  • To evaluate the impact of the RNTCP and DOTS strategy on tuberculosis control in India.
  • To highlight the challenges posed by MDR-TB and the planned expansion of DOTS-Plus.
  • To emphasize the need for medical practitioner cooperation in combating tuberculosis.

Main Methods:

  • Analysis of RNTCP program data and case fatality rates.
  • Review of national strategies for tuberculosis control, including DOTS and planned DOTS-Plus.
  • Assessment of the evolving landscape of tuberculosis, including co-infections with HIV and drug resistance.

Main Results:

  • The RNTCP, implemented nationwide by March 2006, has significantly reduced case fatality rates from 29% to 4% in new smear-positive cases since 1993.
  • Emergence of multidrug-resistant tuberculosis (MDR-TB) presents a major public health concern.
  • India plans to implement DOTS-Plus nationwide by 2010 and ensure access to MDR-TB diagnosis and treatment by 2012.

Conclusions:

  • The RNTCP and DOTS strategy have been effective in reducing tuberculosis mortality in India.
  • Addressing MDR-TB, XDR-TB, and TB/HIV co-infections requires enhanced control measures and treatment accessibility.
  • The cooperation of medical practitioners is crucial for the successful control of tuberculosis.